Assignment, Assumption and Amendment to Credit Agreement (September 30th, 2011)
This Assignment, Assumption and Amendment to Credit Agreement (this "Amendment"), dated as of September 28, 2011 (the "Effective Date"), is entered into among CORE LABORATORIES N.V., a Netherlands limited liability company, (the "Parent"), and CORE LABORATORIES LP, a Delaware limited partnership (the "Current US Borrower" and, together with the Parent, the "Current Borrowers" and, each a "Current Borrower"), CORE LABORATORIES (U.S.) INTERESTS HOLDINGS, INC., a Texas corporation ("Core Laboratories Interests Holdings"), the lenders party to the Credit Agreement described below, and BANK OF AMERICA, N.A., as Administrative Agent (in such capacity, the "Administrative Agent"), Swing Line Lender and L/C Issuer.
Core Laboratories Lp .25% Senior Exchangeable Notes Due 2011 Guaranteed by Core Laboratories N.V. Purchase Agreement (November 6th, 2006)
Core Laboratories, LP, a Delaware limited partnership (the Company), proposes to issue and sell to the initial purchasers listed on Schedule A hereto (the Initial Purchasers) for whom you are the representatives $250,000,000 principal amount of its .25% Exchangeable Notes Due 2011 (the Firm Notes) to be issued pursuant to the provisions of an Indenture to be dated as of November 6, 2006 (the Indenture) among the Company, the Guarantor (as defined below) and Wells Fargo Bank, National Association as Trustee (the Trustee). The Company also proposes to issue and sell to the Initial Purchasers not more than an additional $50,000,000 principal amount of its .25% Senior Exchangeable Notes Due 2011, solely to cover over-allotments (the Additional Notes) if and to the extent the Initial Purchasers elect to exercise the right to purchase such Additional Notes granted to the Initial Purchasers in Section 2 hereof. The Firm Notes and the Additional Notes, together with the Guarantees (as defined